Skip to main content
H

Huaren Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 300110 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,010 across all filing types
Latest filing 2026-04-23 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300110

About Huaren Pharmaceutical Co.,Ltd.

https://www.qdhuaren.com

Huaren Pharmaceutical Co., Ltd. specializes in the research, development, manufacturing, and distribution of high-quality pharmaceutical products and medical supplies. The company is a leading provider of large-volume parenteral (LVP) solutions, particularly non-PVC soft bag intravenous infusions, which are utilized across various clinical settings. Its product portfolio encompasses basic infusions, therapeutic infusions, and specialized solutions such as peritoneal dialysis fluids for the treatment of end-stage renal disease. In addition to its core pharmaceutical offerings, the company produces medical consumables, pharmaceutical packaging materials, and health-related products. Huaren Pharmaceutical emphasizes technological innovation and quality control in its production processes to ensure patient safety and clinical efficacy. The company serves a broad network of healthcare institutions, focusing on delivering integrated solutions for fluid therapy and specialized medical care.

Recent filings

Filing Released Lang Actions
2025年度独立董事述职报告（范英杰）
Governance Information Classification · 1% confidence The document is titled “2025年度独立董事述职报告” (Independent Director’s Annual Performance Report) by范英杰, detailing attendance at board and committee meetings, communication with auditors, protection of investor rights, and governance-related duties. It is not a financial statement (10-K, IR), not an earnings release, not a proxy or dividend notice, nor a management change announcement. Instead, it is a corporate governance disclosure focused on board processes, independent director duties, and governance practices. Thus it falls under Governance Information (CGR).
2026-04-23 Chinese
内部控制审计报告
Audit Report / Information Classification · 1% confidence The document is an independent auditor’s report specifically on the effectiveness of the company’s internal control over financial reporting (内部控制审计报告). It is a standalone audit report issued by a CPA firm, not part of an annual or interim management discussion, nor an announcement of a report publication. This matches the definition of an Audit Report / Information (Code: AR).
2026-04-23 Chinese
2025年度内部控制自我评价报告
Governance Information Classification · 1% confidence The document is the full “2025年度内部控制自我评价报告” issued by the Board describing internal control objectives, evaluation scope, methodologies, results and remediation. It is substantive governance content on internal control systems, corporate structure, risk management and oversight. This aligns with “Governance Information” (CGR) rather than an earnings release, annual report, or simple publication announcement.
2026-04-23 Chinese
中兴华会计师事务所（特殊普通合伙）关于公司2025年度营业收入扣除情况的专项审核意见
Audit Report / Information Classification · 1% confidence The document is a standalone audit opinion (“专项审核意见”) issued by a certified public accountants firm on the company’s 2025 revenue deduction schedule. It is not the full annual report but a specific audit report focused on revenue deduction, fitting the definition of an Audit Report/Information. Therefore, it is classified as AR.
2026-04-23 Chinese
2025年度独立董事述职报告（冯根福，已离任）
Governance Information Classification · 1% confidence The document is a 2025 annual performance report (“述职报告”) by an independent director, detailing board attendance, committee work, oversight activities and governance compliance. It is not a financial statement (10-K/IR), not an earnings release, not a change announcement, nor a proxy or dividend notice. It constitutes a governance disclosure on board and committee practices, best fitting the Governance Information category (CGR).
2026-04-23 Chinese
关于参加2026年青岛辖区上市公司投资者网上集体接待日暨2025年度业绩说明会活动的公告
Regulatory Filings Classification · 1% confidence The document is a brief corporate announcement (526 characters) notifying investors of the company’s participation in an online investor reception and annual performance briefing event. It does not include actual financial data, slides, or attach any report; rather, it is an event notice. This does not fit any specialized category (e.g., earnings release, dividend notice, share issue) and is a general regulatory announcement. Therefore, it falls under the fallback category Regulatory Filings (RNS).
2026-04-23 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.